Cargando…
A recombinant Lactobacillus plantarum strain expressing the spike protein of SARS-CoV-2
Coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global pandemic in the past four months and causes respiratory disease in humans of almost all ages. Although several drugs have been announced to be partially effective...
Autores principales: | Wang, Maopeng, Fu, Tingting, Hao, Jiayi, Li, Letian, Tian, Mingyao, Jin, Ningyi, Ren, Linzhu, Li, Chang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260514/ https://www.ncbi.nlm.nih.gov/pubmed/32485251 http://dx.doi.org/10.1016/j.ijbiomac.2020.05.239 |
Ejemplares similares
-
Mucosal IgA response elicited by intranasal immunization of Lactobacillus plantarum expressing surface-displayed RBD protein of SARS-CoV-2
por: Li, Letian, et al.
Publicado: (2021) -
A micro-sized vaccine based on recombinant Lactiplantibacillus plantarum fights against SARS-CoV-2 infection via intranasal immunization
por: Li, Letian, et al.
Publicado: (2023) -
The “LLQY” Motif on SARS-CoV-2 Spike Protein Affects S Incorporation into Virus Particles
por: Du, Shouwen, et al.
Publicado: (2022) -
Immunogenicity and protective potential of chimeric virus-like particles containing SARS-CoV-2 spike and H5N1 matrix 1 proteins
por: Chen, Jing, et al.
Publicado: (2022) -
Construction, expression and antiviral activity analysis of recombinant adenovirus expressing human IFITM3 in vitro
por: Du, Shouwen, et al.
Publicado: (2019)